Paul Joyce

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 53

Top Venues

Pharmaceutics

ACS infectious diseases

Molecular pharmaceutics

Langmuir : the ACS journal of surfaces and colloids

University of South Australia

University of South Australia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of South Australia Sep 01 2019

Australia

Postdoctoral Research Associate :: Clinical and Health Sciences

Chalmers tekniska högskola Jan 01 2019 - Oct 01 2019

Sweden

Research Scientist :: Department of Physics

Chalmers tekniska högskola Jan 01 2017 - Dec 31 2018

Sweden

ÅForsk Research Fellow :: Division of Biological Physics

University of South Australia - Mawson Lakes Campus Nov 30 2015 - Dec 31 2016

Australia

Research Associate :: Future Industries Institution

Education History

University of South Australia Jun 01 2012 - Jun 28 2016

Australia

PHD :: School of Pharmacy and Medical Sciences

University of Adelaide Feb 01 2007 - Nov 30 2011

Australia

BSC :: School of Chemical Engineering

Publications

Anam Ahsan, Nicky Thomas, Timothy J Barnes, Santhni Subramaniam, Thou Chen Loh, Paul Joyce, Clive A Prestidge
Lipid Nanocarriers-Enabled Delivery of Antibiotics and Antimicrobial Adjuvants to Overcome Bacterial Biofilms. Pharmaceutics 16 (3) (2024)
Thao M Nguyen, Paul Joyce, David Morrall Ross, Kristen E Bremmell, Manasi Jambhrunkar, Sook S Wong, Clive A Prestidge
Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax. Pharmaceutics 16 (2) (2024)
Santhni Subramaniam, Paul Joyce, Abiodun D Ogunniyi, Admire Dube, Samantha L Sampson, Claus-Michael Lehr, Clive A Prestidge
Minimum Information for Conducting and Reporting In Vitro Intracellular Infection Assays. ACS infectious diseases 10 (2) (2024)
Amin Ariaee, Hannah R Wardill, Anthony Wignall, Clive A Prestidge, Paul Joyce
The Degree of Inulin Polymerization Is Important for Short-Term Amelioration of High-Fat Diet (HFD)-Induced Metabolic Dysfunction and Gut Microbiota Dysbiosis in Rats. Foods (Basel, Switzerland) 13 (7) (2024)
Santhni Subramaniam, Paul Joyce, Charlotte E Conn, Clive A Prestidge
Cellular uptake and in vitro antibacterial activity of lipid-based nanoantibiotics are influenced by protein corona. Biomaterials science 12 (13) (2024)
Anam Ahsan, Nicky Thomas, Timothy J Barnes, Santhni Subramaniam, Thou Chen Loh, Paul Joyce, Clive A Prestidge
Lipid Nanocarriers-Enabled Delivery of Antibiotics and Antimicrobial Adjuvants to Overcome Bacterial Biofilms. Pharmaceutics 16 (3) (2024)
Srinivas Kamath, Alexander Hunter, Kate Collins, Anthony Wignall, Paul Joyce
The atypical antipsychotics lurasidone and olanzapine exert contrasting effects on the gut microbiome and metabolic function of rats. British journal of pharmacology (2024)
Santhni Subramaniam, Paul Joyce, Abiodun D Ogunniyi, Admire Dube, Samantha L Sampson, Claus-Michael Lehr, Clive A Prestidge
Minimum Information for Conducting and Reporting In Vitro Intracellular Infection Assays. ACS infectious diseases (2024)
Rebecca Kerstens, Paul Joyce
The Gut Microbiome as a Catalyst and Emerging Therapeutic Target for Parkinson's Disease: A Comprehensive Update. Biomedicines 12 (8) (2024)
Amin Ariaee, Hannah R Wardill, Anthony Wignall, Clive A Prestidge, Paul Joyce
The Degree of Inulin Polymerization Is Important for Short-Term Amelioration of High-Fat Diet (HFD)-Induced Metabolic Dysfunction and Gut Microbiota Dysbiosis in Rats. Foods (Basel, Switzerland) 13 (7) (2024)
Santhni Subramaniam, Paul Joyce, Charlotte E Conn, Clive A Prestidge
Cellular uptake and in vitro antibacterial activity of lipid-based nanoantibiotics are influenced by protein corona. Biomaterials science (2024)
Amin Ariaee, Hannah R Wardill, Anthony Wignall, Clive A Prestidge, Paul Joyce
The Degree of Inulin Polymerization Is Important for Short-Term Amelioration of High-Fat Diet (HFD)-Induced Metabolic Dysfunction and Gut Microbiota Dysbiosis in Rats. Foods (Basel, Switzerland) 13 (7) (2024)
Rebecca Kerstens, Paul Joyce
The Gut Microbiome as a Catalyst and Emerging Therapeutic Target for Parkinson's Disease: A Comprehensive Update. Biomedicines 12 (8) (2024)
Santhni Subramaniam, Paul Joyce, Abiodun D Ogunniyi, Admire Dube, Samantha L Sampson, Claus-Michael Lehr, Clive A Prestidge
Minimum Information for Conducting and Reporting In Vitro Intracellular Infection Assays. ACS infectious diseases 10 (2) (2024)
Srinivas Kamath, Paul Joyce
A critical need for 'gut neutrality': mitigating adverse drug-microbiome interactions. Expert opinion on drug metabolism & toxicology (2024)
Santhni Subramaniam, Paul Joyce, Abiodun D Ogunniyi, Admire Dube, Samantha L Sampson, Claus-Michael Lehr, Clive A Prestidge
Minimum Information for Conducting and Reporting In Vitro Intracellular Infection Assays. ACS infectious diseases 10 (2) (2024)
Anam Ahsan, Nicky Thomas, Timothy J Barnes, Santhni Subramaniam, Thou Chen Loh, Paul Joyce, Clive A Prestidge
Lipid Nanocarriers-Enabled Delivery of Antibiotics and Antimicrobial Adjuvants to Overcome Bacterial Biofilms. Pharmaceutics 16 (3) (2024)
Thao M Nguyen, Paul Joyce, David Morrall Ross, Kristen E Bremmell, Manasi Jambhrunkar, Sook S Wong, Clive A Prestidge
Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax. Pharmaceutics 16 (2) (2024)
Paul Joyce, Christine J Allen, María José Alonso, Marianne Ashford, Michelle S Bradbury, Matthieu Germain, Maria Kavallaris, Robert S Langer, Twan Lammers, Maria Teresa Peracchia, Amirali Popat, Clive A Prestidge, Cristianne J F Rijcken, Bruno Sarmento, Ruth B Schmid, Avi Schroeder, Santhni Subramaniam, Chelsea R Thorn, Kathryn A Whitehead, Chun-Xia Zhao, Hélder Almeida Santos
A translational framework to DELIVER nanomedicines to the clinic. Nature nanotechnology (2024)
Santhni Subramaniam, Paul Joyce, Abiodun D Ogunniyi, Admire Dube, Samantha L Sampson, Claus-Michael Lehr, Clive A Prestidge
Minimum Information for Conducting and Reporting In Vitro Intracellular Infection Assays. ACS infectious diseases 10 (2) (2024)
Santhni Subramaniam, Paul Joyce, Abiodun D Ogunniyi, Admire Dube, Samantha L Sampson, Claus-Michael Lehr, Clive A Prestidge
Minimum Information for Conducting and Reporting In Vitro Intracellular Infection Assays. ACS infectious diseases 10 (2) (2024)
Sajedeh Maghrebi, Nicky Thomas, Clive A Prestidge, Paul Joyce
Inulin-lipid hybrid (ILH) microparticles promote pH-triggered release of rifampicin within infected macrophages. Drug delivery and translational research (2023)
Muhammed Awad, Zlatko Kopecki, Timothy J Barnes, Anthony Wignall, Paul Joyce, Nicky Thomas, Clive A Prestidge
Lipid Liquid Crystal Nanoparticles: Promising Photosensitizer Carriers for the Treatment of Infected Cutaneous Wounds. Pharmaceutics 15 (2) (2023)
Thao M Nguyen, Manasi Jambhrunkar, Sook S Wong, David M Ross, Paul Joyce, John W Finnie, Jim Manavis, Kristen Bremmell, Melissa R Pitman, Clive A Prestidge
Targeting Acute Myeloid Leukemia Using Sphingosine Kinase 1 Inhibitor-Loaded Liposomes. Molecular pharmaceutics (2023)
Srinivas Kamath, Andrea M Stringer, Clive A Prestidge, Paul Joyce
Targeting the gut microbiome to control drug pharmacomicrobiomics: The next frontier in oral drug delivery. Expert opinion on drug delivery (2023)
Amalie Møller, Hayley B Schultz, Tahlia R Meola, Paul Joyce, Anette Müllertz, Clive A Prestidge
The Influence of Blonanserin Supersaturation in Liquid and Silica Stabilised Self-Nanoemulsifying Drug Delivery Systems on In Vitro Solubilisation. Pharmaceutics 15 (1) (2023)
Amalie Møller, Hayley B Schultz, Tahlia R Meola, Paul Joyce, Anette Müllertz, Clive A Prestidge
The Influence of Blonanserin Supersaturation in Liquid and Silica Stabilised Self-Nanoemulsifying Drug Delivery Systems on In Vitro Solubilisation. Pharmaceutics 15 (1) (2023)
Muhammed Awad, Zlatko Kopecki, Timothy J Barnes, Anthony Wignall, Paul Joyce, Nicky Thomas, Clive A Prestidge
Lipid Liquid Crystal Nanoparticles: Promising Photosensitizer Carriers for the Treatment of Infected Cutaneous Wounds. Pharmaceutics 15 (2) (2023)
Santhni Subramaniam, Srinivas Kamath, Amin Ariaee, Clive Prestidge, Paul Joyce
The impact of common pharmaceutical excipients on the gut microbiota. Expert opinion on drug delivery (2023)
Amalie Møller, Hayley B Schultz, Tahlia R Meola, Paul Joyce, Anette Müllertz, Clive A Prestidge
The Influence of Blonanserin Supersaturation in Liquid and Silica Stabilised Self-Nanoemulsifying Drug Delivery Systems on In Vitro Solubilisation. Pharmaceutics 15 (1) (2023)
Muhammed Awad, Zlatko Kopecki, Timothy J Barnes, Anthony Wignall, Paul Joyce, Nicky Thomas, Clive A Prestidge
Lipid Liquid Crystal Nanoparticles: Promising Photosensitizer Carriers for the Treatment of Infected Cutaneous Wounds. Pharmaceutics 15 (2) (2023)
Sajedeh Maghrebi, Nicky Thomas, Clive A Prestidge, Paul Joyce
Inulin-lipid hybrid (ILH) microparticles promote pH-triggered release of rifampicin within infected macrophages. Drug delivery and translational research (2023)
Amalie Møller, Hayley B Schultz, Tahlia R Meola, Paul Joyce, Anette Müllertz, Clive A Prestidge
The Influence of Blonanserin Supersaturation in Liquid and Silica Stabilised Self-Nanoemulsifying Drug Delivery Systems on In Vitro Solubilisation. Pharmaceutics 15 (1) (2023)
Muhammed Awad, Zlatko Kopecki, Timothy J Barnes, Anthony Wignall, Paul Joyce, Nicky Thomas, Clive A Prestidge
Lipid Liquid Crystal Nanoparticles: Promising Photosensitizer Carriers for the Treatment of Infected Cutaneous Wounds. Pharmaceutics 15 (2) (2023)
Md Musfizur Hassan, Bilquis Romana, Guangzhao Mao, Naresh Kumar, Fabio Sonvico, Pall Thordarson, Paul Joyce, Kristen E Bremmell, Timothy J Barnes, Clive A Prestidge
Liposome-Micelle-Hybrid (LMH) Carriers for Controlled Co-Delivery of 5-FU and Paclitaxel as Chemotherapeutics. Pharmaceutics 15 (7) (2023)
Leah Wright, Timothy J Barnes, Paul Joyce, Clive A Prestidge
Optimisation of a High-Throughput Model for Mucus Permeation and Nanoparticle Discrimination Using Biosimilar Mucus. Pharmaceutics 14 (12) (2022)
Leah Wright, Timothy J Barnes, Paul Joyce, Clive A Prestidge
Optimisation of a High-Throughput Model for Mucus Permeation and Nanoparticle Discrimination Using Biosimilar Mucus. Pharmaceutics 14 (12) (2022)
JingYi Chen, John P Hanrahan, Joe McGrath, Melissa A Courtney, Clive A Prestidge, Paul Joyce
The Anti-Obesity Effect of Porous Silica Is Dependent on Pore Nanostructure, Particle Size, and Surface Chemistry in an In Vitro Digestion Model. Pharmaceutics 14 (9) (2022)
Wen Wang, Paul Joyce, Kristen Bremmell, Robert Milne, Clive A Prestidge
Liposomal 5-Fluorouracil Polymer Complexes Facilitate Tumor-Specific Delivery: Pharmaco-Distribution Kinetics Using Microdialysis. Pharmaceutics 14 (2) (2022)
Leah Wright, Timothy J Barnes, Paul Joyce, Clive A Prestidge
Optimisation of a High-Throughput Model for Mucus Permeation and Nanoparticle Discrimination Using Biosimilar Mucus. Pharmaceutics 14 (12) (2022)
Ruba Almasri, Hayley B Schultz, Amalie Møller, Kristen E Bremmell, Alfonso E Garcia-Bennett, Paul Joyce, Clive A Prestidge
Role of Silica Intrawall Microporosity on Abiraterone Acetate Solubilization and In Vivo Oral Absorption. Molecular pharmaceutics 19 (4) (2022)
Muhammed Awad, Timothy J Barnes, Nicky Thomas, Paul Joyce, Clive A Prestidge
Gallium Protoporphyrin Liquid Crystalline Lipid Nanoparticles: A Third-Generation Photosensitizer against Pseudomonas aeruginosa Biofilms. Pharmaceutics 14 (10) (2022)
Leah Wright, Timothy J Barnes, Paul Joyce, Clive A Prestidge
Optimisation of a High-Throughput Model for Mucus Permeation and Nanoparticle Discrimination Using Biosimilar Mucus. Pharmaceutics 14 (12) (2022)
Leah Wright, Paul Joyce, Timothy J Barnes, Clive A Prestidge
Mimicking the Gastrointestinal Mucus Barrier: Laboratory-Based Approaches to Facilitate an Enhanced Understanding of Mucus Permeation. ACS biomaterials science & engineering (2021)
Erik Olsén, Silver Jõemetsa, Adrián González, Paul Joyce, Vladimir P Zhdanov, Daniel Sundås Midtvedt, Fredrik Höök
Diffusion of Lipid Nanovesicles Bound to a Lipid Membrane Is Associated with the Partial-Slip Boundary Condition. Nano letters 21 (19) (2021)
Oliver J Hedge, Fredrik Höök, Paul Joyce, Christel A S Bergstrom
Investigation of Self-Emulsifying Drug-Delivery System Interaction with a Biomimetic Membrane under Conditions Relevant to the Small Intestine. Langmuir : the ACS journal of surfaces and colloids 37 (33) (2021)
Shakhawath Hossain, Paul Joyce, Albin Parrow, Silver Jõemetsa, Fredrik Höök, Per Larsson, Christel A S Bergstrom
Influence of Bile Composition on Membrane Incorporation of Transient Permeability Enhancers. Molecular pharmaceutics 17 (11) (2020)
Paul Joyce, Hanna Ulmefors, Alfonso E Garcia-Bennett, Clive A Prestidge
Microporosity, Pore Size, and Diffusional Path Length Modulate Lipolysis Kinetics of Triglycerides Adsorbed onto SBA-15 Mesoporous Silica Particles. Langmuir : the ACS journal of surfaces and colloids 36 (13) (2020)
Sajedeh Maghrebi, Manasi Jambhrunkar, Paul Joyce, Clive A Prestidge
Engineering PLGA-Lipid Hybrid Microparticles for Enhanced Macrophage Uptake. ACS applied bio materials 3 (7) (2020)
Sajedeh Maghrebi, Paul Joyce, Manasi Jambhrunkar, Nicky Thomas, Clive A Prestidge
Poly(lactic-co-glycolic) Acid-Lipid Hybrid Microparticles Enhance the Intracellular Uptake and Antibacterial Activity of Rifampicin. ACS applied materials & interfaces 12 (7) (2020)
Paul Joyce, Tahnee J Dening, Tahlia R Meola, Anthony Wignall, Hanna Ulmefors, Miia Kovalainen, Clive A Prestidge
Contrasting Anti-obesity Effects of Smectite Clays and Mesoporous Silica in Sprague-Dawley Rats. ACS applied bio materials 3 (11) (2020)
Paul Joyce, Hanna Ulmefors, Sajedeh Maghrebi, Santhni Subramaniam, Anthony Wignall, Silver Jõemetsa, Fredrik Höök, Clive A Prestidge
Enhancing the Cellular Uptake and Antibacterial Activity of Rifampicin through Encapsulation in Mesoporous Silica Nanoparticles. Nanomaterials (Basel, Switzerland) 10 (4) (2020)
Silver Jõemetsa, Paul Joyce, Quentin Lubart, Mokhtar Mapar, Emanuele Celauro, Björn Agnarsson, Stephan Block, Marta Bally, Elin K Esbjörner, Gavin D M Jeffries, Fredrik Höök
Independent Size and Fluorescence Emission Determination of Individual Biological Nanoparticles Reveals that Lipophilic Dye Incorporation Does Not Scale with Particle Size. Langmuir : the ACS journal of surfaces and colloids 36 (33) (2020)

Paul Joyce.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Paul Joyce